Lipid Metabolism in Lipoatrophic Diabetes

G. Enzi; M. Digito; G. Baldo-Enzi; L. Cominacini; G. Dodi; R. Carraro; F. Zurlo

doi:10.1055/s-2007-1010891

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 1988; 20(9): 587-591
DOI: 10.1055/s-2007-1010891

Clinical

Lipid Metabolism in Lipoatrophic Diabetes

G. Enzi¹ , M. Digito¹ , G. Baldo-Enzi¹ , L. Cominacini² , G. Dodi³ , R. Carraro¹ , F. Zurlo¹

¹Department of Internal Medicine, University of Padua, Italy
²Department of Internal Medicine, University of Verona, Italy
³Department of Surgery, University of Padua, Italy

Abstract

PDF Download

Summary

Some aspects of lipid metabolism were studied in 4 patients with a congenital lipoatrophic diabetes (LAD) associated to a type IV hyperlipoproteinemia.

The analysis of lipoprotein composition, expressed as mg/dl, demonstrates a significant increase of VLDL mass and a significant reduction of MDL mass. The analysis of lipoprotein composition, expressed as per cent of total mass demonstrates an increase of the triglyceride content in all fractions and a significant reduction of the cholesterol and phospholipid content in HDL₂ particles. Apo C-II, C-III_0, C-III₁ and C-III₂ levels in lipoprotein fractions were normal in LAD patients. Lipoprotein lipase activity in omental adipose tissue, collected during laparoscopy in one patient was undetectable. The serum of this patient did not fully activate the lipoprotein lipase eluted from normal adipose tissue.

In all patients the adipose tissue lipoprotein lipase activity in post-heparin plasma was blunted or near absent. Thus a reduced peripheral clearance of triglyceride-rich lipoprotein could be an important determinant of lipoprotein abnormalities in lipoatrophic diabetes.

Key-Words

Lipoatrophic Diabetes - Adipose Tissue Lipoprotein Lipase Activity - Plasma Post-Heparin Lipolytic Activity - Lipoprotein Composition

PDF (532 kb)